Biotech

All Articles

AvenCell bags $112M to snap 'switchable' CAR-Ts in the medical clinic

.AvenCell Therapies has secured $112 million in series B funds as the Novo Holdings-backed biotech f...

China- based biotech plans ph. 3 after seeing midstage eye records

.China-based Minghui Pharmaceutical has actually linked its own thyroid eye health condition procedu...

Sangamo slashes opportunity to market for Fabry genetics therapy as FDA accepts to sped up permission bundle

.Sangamo Therapies has pinpointed a shortcut to market for its Fabry condition candidate, aligning w...

Otsuka's renal ailment medicine improves UPCR levels in ph. 3 test

.Otsuka Drug's renal illness medicine has reached the major endpoint of a period 3 trial through sho...

Roche throws out $120M tau prospect, sending back liberties to UCB

.Roche has given back the civil rights to UCB's anti-tau antitoxin bepranemab, walking away from a $...

Editas strengthens in vivo tactic by means of $238M Genenvant treaty

.Editas Medicines has signed a $238 thousand biobucks pact to combine Genevant Science's fat nanopar...

Combo end results, Vicodin overlook as well as stellar safety

.Tip has stated phase 3 records on its own near-approval discomfort drug prospect suzetrigine, eluci...

Angelini markers $360M biobucks pact for ph. 1 mind ailment drug

.Italy's Angelini Pharma has signed a $360 million biobucks deal fixated a phase 1-stage brain healt...

Sage gives up half of R&ampD group as well as shakes up C-suite once again

.Sage Rehabs' most current try to diminish its pipe and also staff will definitely view a third of t...

With stage 1 record, Feeling has an eye on early-stage sac cancer cells

.With its own lead applicant in a period 3 test for an uncommon eye cancer, Feeling Biosciences is w...